Pheezee is designed to assess musculoskeletal and neuromuscular health
Startoon Labs, a Hyderabad-based ISO 13485:2016 and ISO 9001:2015 Certified medical device R&D, Engineering and Manufacturing Company with a focus on Joint health received US FDA (The US Food and Drug Administration) (510 K Exempt) clearance for its wearable device PHEEZEE.
Suresh Susurla, Founder & CEO said, “Pheezee is a patented technology, capable of measuring the surface Electromyogram (sEMG) of bulk muscles and Range of motion (ROM) of primary joints simultaneously, to determine joint health, making it a one-of-a-kind product in the world with this capability.”
Pheezee is helpful in assessing joint health during physiotherapy post musculoskeletal, neurological, spinal cord injuries and neuro-ailments such as paralysis, hemiplegia, paraplegia, muscular dystrophy etc. It generates reports, for the first time in the field of physiotherapy, enabling patients to track their recovery. Pheezee, being an IOT-enabled device, enables telerehabilitation of the patients and allows them to continue doing physiotherapy sessions at home and still keep the referring surgeon updated about the progress.
Mythreyi Kondapi Co-founder of the medical technology startup said, “It is a revolutionary device set to transform the way assessments, monitoring and tracking of recovery is done in the field of physiotherapy.”
Utilising advanced technology like Electromyography and Range of Motion monitoring, Pheezee measures and tracks the recovery of patients post musculoskeletal and neurological ailments. The device finds usage in joint health assessments in multiple musculoskeletal diseases, including arthritis, muscle dystrophy, carpal tunnel syndrome (which affects 64.4 per cent of IT professionals), and many more in their early stages.